hers com semaglutide reviews before and after Hims & Hers Launches New Pill That Sends Shockwaves Across Weight-Loss Drugmakers' Stocks Novo Nordisk Files Patent Lawsuit

Insurance Coverage and Prior Authorization Insurance plays a critical role in accessing medical weight loss solutions

Side-effects and possible issues with long-term use of these novel agents have yet to be fully evaluated

Heart 102 (11), 841848

MedicalDaily Evidence Check Study type: Phase 3 randomized controlled trial (ATTAIN program) Participants: Adults with obesity or overweight with at least one weight-related comorbidity Approval date: April 1, 2026 What it found: Average weight loss of approximately 12.4% (about 27 lbs) at highest dose over 72 weeks What it did not prove: That it matches injectable GLP-1 efficacy

Most Victoza side effects are associated with the digestive system

Outcomes are seen with consistent medication use, a healthy diet, and regular exercise